Month: May 2020

Philadelphia, PA, May 29, 2020 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) (OTC:VSBGF) (“VSBLTY”), a leading retail software technology company, in partnership with IMG, a global leader in sports events and media, conducted an audience study at the 106th Rose Bowl Game in Pasadena, Calif. on January 1, 2020. The research captured operational and marketing data that will help operators of entertainment and sports venues make informed decisions on staffing levels and guest experiences.Jay Hutton, VSBLTY Co-founder and CEO, said, “Traffic count and other venue data collected, when combined with machine learning, can help improve operational efficiencies and venue logistics. Facts about fans, their habits and actions—in addition to demographic and psychographic information—will help plan audience activities...

SALT LAKE CITY, May 29, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced the presentation of two new studies at the 2020 American Society of Clinical Oncology (ASCO) annual meeting demonstrating the ability of Myriad’s riskScore® test to provide personalized breast cancer risk information that allows patients and physicians to make better informed clinical treatment decisions.“We are excited to further demonstrate Myriad’s commitment to providing the best possible risk assessment tools to patients through innovation,” said Nicole Lambert, president of Myriad Oncology, Myriad Women’s Health and Myriad International. “The validation data we are presenting at ASCO this year will support a broader launch of riskScore to even more women in the coming...

INDIANAPOLIS, May 29, 2020 (GLOBE NEWSWIRE) — Kite Realty Group Trust (NYSE:KRG) announced today the implementation of its Re-Opening Resources program. KRG has launched a series of initiatives across its portfolio to help its retail, restaurant, and service tenants navigate the process of re-opening their businesses.“Throughout KRG’s portfolio, our tenants have worked hard to adapt to a very fluid environment,” said John Kite, Chairman and CEO of Kite Realty Group. “As re-openings continue, we are encouraged by the effort and ingenuity that businesses have displayed at all of our centers, and we will continue to seek creative opportunities to support our retailers.”KRG efforts underway include:Priority Pick-Up Parking Program: Designated Order Pick-Up parking zones are being professionally installed for use by all tenantsContactless...

MINNEAPOLIS and TORONTO and SINGAPORE, May 29, 2020 (GLOBE NEWSWIRE) — Ceridian (NYSE: CDAY; TSX: CDAY), a global leader in human capital management (HCM) technology, today announced it has completed the acquisition of Excelity Global Solutions Pte Ltd. (Excelity), an Asia-based HCM service provider from the Everstone Group. The acquisition was previously announced on May 5, 2020 and closed and became effective today.“The acquisition of Excelity is an important next step in our global expansion and builds on our recent investment in Australia and New Zealand. We welcome our new colleagues, customers and partners, and we look forward to extending our HCM leadership in the Asia Pacific Japan region,” said David Ossip, Chairman and CEO, Ceridian. “Ceridian has 4,480 customers on the Dayforce cloud platform, and we are excited to bring...

Open pivotal study in pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) with orphan and fast track approvalPreparing for pivotal study in bullous pemphigoid (BP) following recent completion of successful Phase II studyPositive EMA opinion on orphan designation for nomacopan for BP along with Orphan Drug designation granted by FDA in BPNEW YORK and LONDON, May 29, 2020 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where complement (C5) and/or leukotriene (LTB4) systems are implicated, today announced financial results for the first quarter ended March 31, 2020, as well as recent clinical progress.“We remain focused on our mission of addressing severe inflammatory...

HAMILTON, Ontario, May 29, 2020 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare announced that the interim consolidated financial statements (“Financial Statements”) and Management’s Discussion and Analysis (“MD&A”) for the quarter ended March 31, 2020, are now available on the Company’s profile on SEDAR (www.sedar.com).  The Company is also pleased to provide the following corporate update.As previously announced, Reliq will be hosting a webinar today, May 29th at 9:00am EDT at https://bit.ly/2yooZZd.  For those who are not able to attend the webinar, a recording of the webinar will be available on the Company’s website immediately following...

Richland WA, May 29, 2020 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL), Vivos Inc Resumes IsoPet Animal Cancer TherapyAfter several months of virus-related stand-down IsoPet therapy has been scheduled for the week of June 20. Our East Coast Y-90 supplier, our Texas production site and Vista Veterinary Hospital, our pilot clinic located in Kennewick, WA are all geared to support this therapy. The pet parents will be driving 12 hours from California to take advantage of this new technology.Dr. Mike Korenko stated “It was important during the height of the COVID pandemic to protect our team. We are now confident we can proceed safely.”About Vivos Inc. (OTCQB: RDGL)Vivos Inc. has developed an Yttrium-90 based brachytherapy injectable device, for the treatment of tumors in animals (Isopet®) and in humans (Radiogel™). Brachytherapy uses...

WINTER SPRINGS, Fla., May 29, 2020 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s President and Chief Executive Officer after the departure of Leslie McDonnell, who separated from the Company effective May 28, 2020.“I look forward to resuming as the Company’s President and CEO and would like to thank Ms. McDonnell for her contributions during her tenure,” said Roger Susi, President and Chief Executive Officer of the Company. “I remain optimistic about our future and am excited to lead IRADIMED through its next stages of growth,” said Susi.About IRADIMED CORPORATIONIRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider...

ROCKVILLE, Md., May 29, 2020 (GLOBE NEWSWIRE) — Cerecor Inc. (NASDAQ: CERC) today announced that Michael F. Cola, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 2:30 p.m. EDT.A live webcast of the presentation can be accessed under “News/Events” page in the Investors section of the Company’s website at www.cerecor.com.About CerecorCerecor is a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases. The Company is advancing an emerging clinical-stage pipeline of innovative therapies. The Company’s pediatric rare disease pipeline is led by CERC-801, CERC-802 and CERC-803 (“CERC-800 programs”), which are therapies for inborn errors of metabolism,...

– Clear efficacy signal with two ongoing confirmed PSA responses, including one associated with a confirmed RECIST response –– Data represent the first demonstration of PROTAC®-mediated degradation of a disease-causing protein in humans –NEW HAVEN, Conn., May 29, 2020 (GLOBE NEWSWIRE) —  Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced updated data from the dose escalation portion of the company’s Phase 1/2 clinical trial of ARV-110 in men with metastatic castration-resistant prostate cancer (mCRPC), to be shared as an oral presentation at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting on May 29, 2020. ARV-110 is a potent, selective, orally available androgen receptor (AR) degrader,...